C
Coave Therapeutics
2 followers
Coave Therapeutics develops innovative gene therapy products for rare ophthalmic diseases to preserve visual autonomy in affected patients.
Org chart
Rodolphe Clerval
CEO & Director
Collapse
Catherine Mathis
Chief Development Officer
Claudia Mitchell
Interim Chief Scientific Officer
Julien Berger
VP, Legal Affairs & Corporate Secretary
Cédric Cousteix
Finance Director
Lolita Petit
Chief Scientific Officer
Board & advisors
Benedikt Timmerman
Chairman
Philippe Monteyne
Director
Thierry Laugel
Director
Bruno Montanari
Director
Olivier Danos
Director
Frederic Chereau
Chairman
Andrea Ballabio
Scientific Advisor
Erwan Bézard
Scientific Advisor
Guillaume Blavier
Director
Aravind Asokan
Scientific Advisor
Robert Kotin
Scientific Advisor
Alain Wagner
Scientific Advisor
Juliette Hordeaux
Scientific Advisor
Anne Des Rieux
Scientific Advisor